본문으로 건너뛰기
← 뒤로

Disease-associated neutrophil heterogeneity in cancer therapy: Implications for precision immunotherapy.

1/5 보강
Critical reviews in oncology/hematology 📖 저널 OA 5.6% 2022: 0/3 OA 2023: 0/2 OA 2024: 0/4 OA 2025: 0/56 OA 2026: 17/236 OA 2022~2026 2026 Vol.220() p. 105182
Retraction 확인
출처

Sui D, Liu F, Zheng L, Yu S, Ding Z, Ren X, Gao J, Wang W, Yang L

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.9%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

Neutrophils exhibit significant heterogeneity and functional plasticity in both healthy and disease states.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Sui D, Liu F, et al. (2026). Disease-associated neutrophil heterogeneity in cancer therapy: Implications for precision immunotherapy.. Critical reviews in oncology/hematology, 220, 105182. https://doi.org/10.1016/j.critrevonc.2026.105182
MLA Sui D, et al.. "Disease-associated neutrophil heterogeneity in cancer therapy: Implications for precision immunotherapy.." Critical reviews in oncology/hematology, vol. 220, 2026, pp. 105182.
PMID 41651316 ↗

Abstract

Neutrophils exhibit significant heterogeneity and functional plasticity in both healthy and disease states. Patients often suffer from multiple conditions simultaneously, complicating disease-associated neutrophil functions. This complexity challenges tumor-related research, yet current studies frequently overlook the functional differences of neutrophils across health and disease, which may contribute to unsatisfactory anti-tumor drug outcomes. This article reviews six conditions that affect neutrophil functions and influence tumor treatment efficacy: inflammation, aging, obesity, diabetes, thrombosis, and liver injury. It highlights how neutrophil phenotypes and functions change under these conditions, potentially altering their roles in tumor immunity and impacting anti-tumor therapies. Furthermore, four anti-tumor strategies targeting neutrophils are discussed, such as neutrophil drug delivery systems, neutrophil reprogramming, regulation of neutrophil extracellular traps, and the use of neutrophil membranes and exosomes. This review offers a novel perspective: for cancer patients with concurrent comorbidities (such as inflammation, aging, obesity, diabetes, thrombosis, and liver injury), tailoring treatment by targeting or leveraging neutrophils in these disease states may be of significant importance.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반